HTN Flashcards

1
Q

primary htn

A

Family history
African American
Hyperlipidemia
Smoking
Age > 60 or post-
menopausal
Excessive sodium or
caffeine intake
Obesity
Sedentary lifestyle
Excessive alcohol
Low potassium,
calcium or
magnesium intake
Excessive stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

secondary htn

A

Kidney disease
Adrenal-mediated
causes:
 Primary aldosteronism
 Pheochromocytoma
 Cushing’s disease
Coarctation of the aorta
Brain tumors
Encephalitis
Pregnancy
Drugs –
 Estrogen
 Glucocorticoids/
mineralocorticoids
 Sympathomimetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is bp

A

co X pvr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is pvr depending on

A

Autonomic Nervous System
Circulating Hormones
 Norepinephrine & Epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pathophysiologic processes

A

Can result from
increases in cardiac
output, peripheral
resistance, or both
Must also be a
problem with the
body’s control
system
Dysfunction of the
autonomic nervous
system
Increased renin–
angiotensin–
aldosterone system
Resistance to
insulin action
Activation of the
immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

heart damage from htn(3)

A

CAD
 Left Ventricular Hypertrophy
 Heart Failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

kidney damage from htn

A

nephrosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

brain damage htn

A

cerebrovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

eye damage htn

A

retinal damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

peripheral vessel damage htn

A

Peripheral Vascular Disease - (more
specifically, Peripheral ARTERIAL
Disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hypertensive emergency

A

BP greater than 180/120 with new or
worsening target organ damage.
Requires critical care monitoring and
intervention:
 Continuous IV infusion of anti-hypertensive
medication
 Frequent, or possibly continuous, BP
monitoring
 Watch for neurological or cardiac
complications:
 Seizures
 Numbness, weakness, tingling of
extremities
 Stroke
 Chest pain, dysrhythmias, LV heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

hypertensive urgency

A

BP greater than 180/120 in stable patients
without target organ damage as evidenced
based on clinical examination and results of
laboratory studies.
Investigate cause of hypertension (ex.
Nonadherence to medications).
Requires close monitoring of blood pressure
and cardiovascular status.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how much sodium for dash diet

A

no more than 2g per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the goal of dash diet

A

,aintain bp <130/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

thiazide diruetics
name(1)
moa
se

A

Hydrochlorothiazide
* Inhibit sodium, chloride, and water
reabsorption
* Monitor for orthostatic hypotension and
hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ccbs
names(3)
moa
se

A

Amlodipine, Diltiazem, Verapamil
* Lower blood pressure by interfering with
the transmembrane flux of calcium ions
resulting in vasodilation
* Side effects of flushing, peripheral
edema, HA
* Block SA and AV node conduction –
decreases HR
* Most effective in older adults and African
Americans

17
Q

ace inhibitors
names(3)
moa
se

A

Captopril, Lisinopril, Enalapril
 Block ACE from converting angiotensin I to angiotensin II –
inhibiting vasoconstriction
 Decreases sodium and water retention at kidneys – lowering
PVR
 Most common side effect is a nagging dry cough
 Monitor for hyperkalemia and orthostatic hypotension
 Caution in clients with renal impairment
 Neutropenia, angioedema (rare but serious)

18
Q

arbs
name(3)
moa
se

A

Losartan, Valsartan, Candesartan
 Block angiotensin II from binding with receptor sites
 Inhibits vasoconstriction
 Decrease sodium and water retention
 Monitor for hyperkalemia and orthostatic hypotension
 Caution in clients with renal impairment

19
Q

ace inhibitors end in….

A

pril

20
Q

arbs end in….

A

sartan

21
Q

loop diruetics
name(1)
moa
se

A

Furosemide
 Inhibit sodium, chloride and water
reabsorption and promote potassium
excretion
 Monitor for orthostatic hypotension and
hypokalemia
 Ototoxicity risk
 Fall Risk in older adults

22
Q

aldosterone antagonist
name1
moa
se

A

Spironolactone
 Competitive inhibitors of aldosterone binding
(doesn’t allow aldosterone to become
functional)
 Side effects: drowsiness, lethargy headache
 Monitor for hyperkalemia (especially if also on
an ACE inhibitor or ARB

23
Q

potassium sparing diuretics
name(1)
moa
se

A

Amiloride
 Blocks sodium reabsorption
 Side effects: drowsiness, lethargy headache
 Monitor for hyperkalemia

24
Q

beta blockers

A

Metoprolol, Atenolol,
Bisoprolol
Cardio-selective – Beta-1
are used in the
management of
hypertension
*Block beta-1 receptors in the
heart and peripheral vessels
Decreases heart rate and
contractility
Monitor for bradycardia,
hypotension, fatigue,
weakness, depression, and
sexual dysfunction
Clients with diabetes need
to be monitored closely for
hypoglycemia (“masked
symptoms”)
Drug of choice for clients
with history of MI or stable
heart failure

25
Q

alpha-adrenergic antagonists
name(3)
moa
se

A

Doxazosin, Prazosin, Terazosin
Block alpha1-adrenergic effects
* Produces peripheral vasodilation
Monitor for orthostatic hypotension
Primarily used for treatment of BPH

26
Q

hydralazine

A

Reduces peripheral vascular resistance
and blood pressure by direct arterial
vasodilation
Can be given PO or IV (for
hypertensive crisis)

27
Q
A